S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
The Day of Financial Reckoning Is Near (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
US Dollar Replaced By "Biden Bucks"? (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
The Day of Financial Reckoning Is Near (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
US Dollar Replaced By "Biden Bucks"? (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
The Day of Financial Reckoning Is Near (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
US Dollar Replaced By "Biden Bucks"? (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
The Day of Financial Reckoning Is Near (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
US Dollar Replaced By "Biden Bucks"? (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
US Dollar Replaced By "Biden Bucks"? (Ad)
NYSE:CAH

Cardinal Health - CAH Stock Forecast, Price & News

$69.11
-1.03 (-1.47%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$68.72
$69.85
50-Day Range
$50.48
$70.14
52-Week Range
$45.85
$71.45
Volume
2.06 million shs
Average Volume
2.80 million shs
Market Capitalization
$18.83 billion
P/E Ratio
10.38
Dividend Yield
2.82%
Price Target
$67.71

Cardinal Health MarketRank™ Forecast

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
0.6% Downside
$68.67 Price Target
Short Interest
Healthy
2.38% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.65
Upright™ Environmental Score
News Sentiment
0.23mentions of Cardinal Health in the last 14 days
Based on 38 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.06%
From $5.37 to $5.91 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.71 out of 5 stars

Medical Sector

88th out of 1,122 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 7 stocks

CAH stock logo

About Cardinal Health (NYSE:CAH) Stock

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Wall Street Analyst Weigh In

CAH has been the subject of several analyst reports. Barclays boosted their target price on shares of Cardinal Health to $67.00 in a research report on Monday. Morgan Stanley decreased their target price on Cardinal Health from $74.00 to $70.00 and set an "overweight" rating for the company in a research report on Thursday, July 14th. Evercore ISI boosted their price objective on Cardinal Health to $75.00 in a report on Monday. Mizuho upped their price objective on Cardinal Health from $58.00 to $66.00 in a research note on Friday, August 12th. Finally, StockNews.com upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 12th. Seven equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of "Hold" and an average target price of $68.67.

Cardinal Health Price Performance

NYSE:CAH traded down $1.03 during mid-day trading on Wednesday, reaching $69.11. The stock had a trading volume of 2,057,828 shares, compared to its average volume of 2,795,163. The firm has a 50 day moving average price of $56.52 and a two-hundred day moving average price of $56.43. The stock has a market capitalization of $18.83 billion, a P/E ratio of 10.38, a P/E/G ratio of 1.53 and a beta of 0.86. Cardinal Health has a one year low of $45.85 and a one year high of $71.45. The company has a debt-to-equity ratio of 5.33, a quick ratio of 0.57 and a current ratio of 1.08.

Cardinal Health (NYSE:CAH - Get Rating) last announced its quarterly earnings data on Thursday, August 11th. The company reported $1.05 earnings per share for the quarter, missing the consensus estimate of $1.17 by ($0.12). Cardinal Health had a negative net margin of 0.51% and a positive return on equity of 568.57%. The company had revenue of $47.10 billion during the quarter, compared to the consensus estimate of $44.82 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The business's revenue for the quarter was up 10.6% compared to the same quarter last year. As a group, analysts expect that Cardinal Health will post 5.37 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, October 15th. Shareholders of record on Monday, October 3rd will be given a $0.4957 dividend. The ex-dividend date is Friday, September 30th. This represents a $1.98 annualized dividend and a yield of 2.87%. Cardinal Health's payout ratio is currently 29.73%.

Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

CAH Stock News Headlines

Productivity, consumer prices, Cardinal Health earns
The Labor Department issues its second-quarter snapshot of U.S. employee productivity Tuesday and its latest monthly index of inflation at the consumer level Wednesday
WVa cities, counties reach $400M settlement with drug firms
West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors
Cardinal Health (NYSE:CAH) Price Target Raised to $75.00
Cardinal Health (NYSE:CAH) Lifted to Strong-Buy at StockNews.com
Cardinal Health (NYSE:CAH) Price Target Raised to $73.00
Cardinal Health (NYSE:CAH) Shares Gap Down After Earnings Miss
Cardinal Health Inc Q4 Profit Increases, but misses estimates
See More Headlines
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

CAH Company Calendar

Ex-Dividend for 7/15 Dividend
6/30/2022
Dividend Payable
7/15/2022
Last Earnings
8/11/2022
Today
8/18/2022
Ex-Dividend for 10/15 Dividend
9/30/2022
Dividend Payable
10/15/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
14149Y10
Employees
46,500
Year Founded
1971

Price Target and Rating

Average Stock Price Forecast
$68.67
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$59.00
Forecasted Upside/Downside
-2.0%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
9 Analysts

Profitability

Net Income
$-933,000,000.00
Pretax Margin
-0.42%

Debt

Sales & Book Value

Annual Sales
$181.36 billion
Cash Flow
$7.65 per share
Book Value
($2.59) per share

Miscellaneous

Free Float
271,310,000
Market Cap
$18.83 billion
Optionable
Optionable
Beta
0.86

Social Links


Key Executives

  • Mr. Michael C. Kaufmann (Age 59)
    CEO & Director
    Comp: $2.28M
  • Mr. Jason M. Hollar (Age 49)
    Chief Financial Officer
    Comp: $1.4M
  • Ms. Jessica L. Mayer (Age 52)
    Chief Legal & Compliance Officer
    Comp: $1.05M
  • Mr. Stephen M. Mason (Age 50)
    Chief Exec. Officer of Medical Segment
    Comp: $1.2M
  • Mr. Victor L. Crawford (Age 60)
    Chief Exec. Officer of Pharmaceutical Segment
    Comp: $1.41M
  • Ms. Patricia M. English (Age 42)
    Sr. VP & Chief Accounting Officer
  • Mr. Brian S. Rice (Age 59)
    Chief Information Officer, Exec. VP & Global Bus. Services
  • Mr. Kevin Moran
    VP of Investor Relations
  • Dr. Michele A. M. Holcomb Ph.D. (Age 54)
    Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer
  • Ms. Ola M. Snow (Age 54)
    Chief HR Officer













CAH Stock - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings
or view top-rated stocks.

What is Cardinal Health's stock price forecast for 2022?

9 brokerages have issued 1-year price targets for Cardinal Health's shares. Their CAH share price forecasts range from $59.00 to $75.00. On average, they expect the company's stock price to reach $68.67 in the next twelve months. This suggests that the stock has a possible downside of 0.6%.
View analysts price targets for CAH
or view top-rated stocks among Wall Street analysts.

How have CAH shares performed in 2022?

Cardinal Health's stock was trading at $51.49 at the beginning of 2022. Since then, CAH shares have increased by 34.2% and is now trading at $69.11.
View the best growth stocks for 2022 here
.

When is Cardinal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our CAH earnings forecast
.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) posted its earnings results on Thursday, August, 11th. The company reported $1.05 EPS for the quarter, missing the consensus estimate of $1.17 by $0.12. The business earned $47.10 billion during the quarter, compared to analysts' expectations of $44.82 billion. Cardinal Health had a positive trailing twelve-month return on equity of 568.57% and a negative net margin of 0.51%. The business's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 EPS.
Read the conference call transcript
.

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Friday, August 12th. Investors of record on Monday, October 3rd will be paid a dividend of $0.4957 per share on Saturday, October 15th. This represents a $1.98 annualized dividend and a dividend yield of 2.87%. The ex-dividend date of this dividend is Friday, September 30th.
Read our dividend analysis for CAH
.

Is Cardinal Health a good dividend stock?

Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.82%. The company has been increasing its dividend for 36 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 29.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CAH will have a dividend payout ratio of 33.50% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY 2023 earnings guidance on Friday, August, 12th. The company provided earnings per share (EPS) guidance of $5.05-$5.40 for the period, compared to the consensus EPS estimate of $5.18. The company issued revenue guidance of -.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (7.48%), Price T Rowe Associates Inc. MD (4.35%), FMR LLC (2.19%), Northern Trust Corp (1.29%), Pzena Investment Management LLC (1.06%) and ProShare Advisors LLC (1.00%).
View institutional ownership trends
.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $69.11.

How much money does Cardinal Health make?

Cardinal Health (NYSE:CAH) has a market capitalization of $18.83 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $6.66 on an earnings per share basis.

How many employees does Cardinal Health have?

The company employs 46,500 workers across the globe.

Does Cardinal Health have any subsidiaries?
The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Access Closure Inc., Aero-Med Ltd., Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, AssuraMed Inc., Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 Inc., Cardinal Health 104 LP, Cardinal Health 105 Inc., Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 Inc., Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Medical Products India Private Limited, Cardinal Health Mexico 244 S. de R.L. de C.V., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health Norway AS, Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Poland Spółlka z ograniczonąa odpowiedzialnośsciąa, Cardinal Health Portugal 513 Unipessoal Lda., Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Specialty Pharmacy LLC, Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Cashel Company Unlimited, Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Curaspan Health Group Inc., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies Inc., Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR Italia S.r.l., KPR Switzerland Sales Gmbh, KPR U.S. LLC, Kendall Patient Recovery BVBA, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Limited Liability Company "Cardinal Health Russia", Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Medtronic - Patient Monitoring & Recovery, Mirixa Corporation, MosaicGPO LLC, NaviHealth, Nippon Covidien Ltd., One Cloverleaf LLC, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises Inc., RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Subsidiary Name, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, mscripts, and mscripts LLC.
Read More
When was Cardinal Health founded?

Cardinal Health was founded in 1971.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.

This page (NYSE:CAH) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.